Analysis
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
Bahaa Abu-Raya, Soren Gantt and Manish Sadarangani
CMAJ August 24, 2020 192 (34) E982-E985; DOI: https://doi.org/10.1503/cmaj.201237
Bahaa Abu-Raya
Vaccine Evaluation Center, BC Children’s Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC
MDSoren Gantt
Vaccine Evaluation Center, BC Children’s Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC
MD PhDManish Sadarangani
Vaccine Evaluation Center, BC Children’s Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC
BM BCh DPhil![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data supplements
Related Articles
- Abu-Raya, B., Gantt, S., & Sadarangani, M. (2020). Difficultés associées à l’évaluation des vaccins contre le SRAS-CoV-2 pendant la pandémie de COVID-19. CMAJ, 192(48), E1691-E1695. Accessed July 27, 2024. https://doi.org/10.1503/cmaj.201237-f.
In this issue
Article tools
Respond to this article
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
Bahaa Abu-Raya, Soren Gantt, Manish Sadarangani
CMAJ Aug 2020, 192 (34) E982-E985; DOI: 10.1503/cmaj.201237
Jump to section
- Article
- How are vaccines usually evaluated before licensure?
- What factors may affect the evaluation of candidate vaccines for SARS-CoV-2?
- What potential vaccine-related harms may be anticipated?
- Why is careful consideration of study population and trial end points important?
- What are some other challenges to the development of SARS-CoV-2 vaccines?
- What are some particular organizational challenges and opportunities of SARS-CoV-2 vaccine trials?
- How should postlicensure assessment of vaccines be conducted?
- Conclusion
- Acknowledgements
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics